HomeTrading IdeasThe Bull Market Is...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April and May, feeding a narrative of declining “US exceptionalism” as the leading technology stocks (known as the “Magnificent 7”) significantly underperformed the broader index.

The April sell-off began with President Trump’s sweeping “Liberation Day” tariff package on April 2. With nearly all sectors hit by tariffs, stocks plunged almost 20% from record highs, officially entering correction territory. To rationalize that decline, the media narratives ran wild after the preceding two years of 20% gains, with the most bearish headlines available. Reports from PineBridge, Standard Chartered, and iA Global Asset Management suggested the end of U.S. exceptionalism as global fund flows shifted. Even Societe Generale’s Alain Bokobza warned that fading confidence could drive a prolonged rotation out of U.S. stocks.

That rotation of fund flows came from the decline in the , which dragged on U.S. returns for international investors. This makes sense as foreign investor returns get hit twice when domestic share prices fall simultaneously with a weaker dollar. That is why there is a negative correlation between those two asset classes.

However, it should be noted that the decline in the dollar this year follows a sharp rally last year, and the bull market in the dollar remains.

Nonetheless, capital flows were reallocated globally, allowing European equities to outperform U.S. markets this year. However, is this the end of “US exceptionalism?”

A Different Picture Emerges

Despite fears of declining US exceptionalism, debts and deficits, a falling dollar, and tariffs, equities rallied from the April lows with unexpected strength. Leading that charge were the very stocks the bearish media proclaimed dead.Mag-7 vs S&P 500 Performance

Equity markets’ technical posture painted a different picture against that pessimistic canvas. By mid-April, after several days of heavy losses, markets rebounded sharply. A 90-day tariff truce announced on April 9 triggered a 9.5% one-day rally in the , the largest since 2008. Despite still‑high inflation and 4.5% bond yields, markets held key support at the 200‑day moving average, suggesting the correction phase had ended.

Most notably, the “dual equity pain trade” further supports the rally. Many institutional investors trimmed U.S. exposure in April, creating underweights that fuel contrarian inflows, particularly back into quality U.S. assets. JPMorgan notes the path of least resistance favors new highs, and fundamentals reinforce that view. As the most recent #BullBearReport pointed out, retail investors piled into US equities ($515 billion) and another $21 billion into “leveraged” equities.Inflows in US Equities

The rebound isn’t surprising, . That pullback “washed out” investor euphoria, paving the way for any “good news” to facilitate gains. To wit:

Whether or not the current market crash is the beginning of a larger corrective cycle, such low readings have, without failure, marked the near-term low of a market correction. While the market has previously continued its corrective process after such low readings, such did not occur without a meaningful reversal rally first..It won’t take much for the market to find a reason to rally. That could happen as soon as next week.Technical Overbought/Sold Composite

That dip served as a healthy reset. Investor sentiment swung from euphoria to skepticism, which is required to continue the bull market.

Fundamentals also underpin this market’s resilience. Employment added 147,000 jobs in June, while in a weakening trend, it is still growing. However, corporate earnings grew steadily across sectors, and the tech-heavy “Magnificent 7” continues to deliver strong results, driving much of the rebound. Despite headlines suggesting Europe is the place for growth, the “Mag 7” stocks drive corporate earnings versus the rest of the index and the world. (h/t @eggswhite)Mag-7 US EPS Exceptionalism

Furthermore, those seven stocks have contributed over $2.4 trillion to market gains since May. This is due to the hefty weighting in the S&P 500 index, which absorbs $0.36 of every dollar invested. Furthermore, the top 10 stocks impact the S&P 500 index the same as the bottom 440 stocks combined.Top 10 Mega-Caps Market Cap

Economically, inflation is easing. Core measures hover near 2.3%, and bond yields stabilized. Long-term Treasury yields around 4.5% reflect a market no longer panicking as yields have normalized to current economic and inflation growth rates. (The left chart shows the difference between current rates and the economic growth and inflation interest rate model.)GDP and CPI vs Rate Model

The “dual equity pain trade” further supports the rally. Many institutional investors trimmed U.S. exposure in April, creating underweights that fuel contrarian inflows, particularly back into quality U.S. assets. JPMorgan notes the path of least resistance favors new highs, and fundamentals reinforce that view.

Global dynamics also play a role. Even amid U.S. outflows, international capital repositioned in Europe and emerging Asia is a rotation, not a complete exit. At the same time, robust inflows into U.S. tech, AI, and large-cap growth show that America’s competitive strength remains intact. Most importantly, the dollar’s recent weakness supports U.S. exports and earnings for multinationals, offsetting earlier fears.

Technically Speaking, The Bull Market Is Intact

Multiple factors have converged to support the recent rally despite the narrative of U.S. decline.

  • The April drawdown reset valuations, reducing euphoria and creating technical support.
  • U.S. economic indicators—jobs, corporate earnings, inflation—remain strong.
  • Institutional repositioning has triggered rebound buying in quality names.
  • Global flows rotate but do not abandon U.S. markets entirely.
  • The Federal Reserve maintains a cautious stance, supporting market confidence.

In other words, as we discussed in “ short-term market declines generate headlines to rationalize events.

“What is most important to investors is that the market absorbs all negative media narratives over the long term. The recent barrage of negative narratives surrounding debts, deficits, tariffs, inflation, wars, Trump, etc., is all just there to feed your negative bias. However, zooming out, investors who have stayed away from investing in the financial markets to “avoid the loss” of potential adverse outcomes have paid a dear price in reduced financial wealth. In other words, there is always a “reason” not to invest. However, the current narrative will change, but the market won’t.”Real S&P 500 Index

The point for investors is that despite headlines and narratives, the bull market’s resilience builds from cold, hard data. Throughout history, we have faced familiar risks: trade policy uncertainty, political volatility, and inflationary pressure.

These elements are part of a broader tapestry already reflected in prices. As shown, the market responded by holding the rising bullish trend line from the October 2022 lows and then accelerating on signs of stabilization. The market rally above key moving averages, the breakout to new highs, and the reversal of the Death Cross” are all very bullish developments suggesting the bulls remain in control.S&P 500 vs 50 and 200-DMA-50-WMA and 15-MMA

With these key resistance levels behind us, and sentiment turning bullish, but not near extremes, this suggests the April “Liberation Day” correction is behind us, and the bull market is continuing.Net-Bullish-Sentiment (Z-Score) vs S&P 500

Despite ongoing headlines from media outlets touting “the end of U.S. exceptionalism,” the correction laid the groundwork for further gains. Technicals validate this trend, while fundamentals, from labor markets to corporate profits, reinforce it. Investors who continue to fall prey to the narrative will eventually realize the data does not support it. Yes, March and April were stormy, but they may have strengthened, not broken, the bull market’s core by providing a healthy correction to reset previous exuberance.

Whether invested in the Magnificent Seven, high-quality cyclicals, or diversified funds, the path forward remains constructive. As we concluded in our articles on market narratives:

I am NOT saying you should passively stand there and let an eventual recessionary bear market or financial event wash over you. Investors can, and should, manage portfolio risk and navigate markets during uncertain times. However, most bearish narratives are like background noise in the investing world.

There will always be a headline or analyst warning you to step aside. Sure, some of those concerns may be valid. However, reacting emotionally, rather than logically, often results in poor investor outcomes.

Most Popular

More from Author

Read Now

Can Trump’s ‘Run It Hot’ Plan Trap the Fed and Jolt the Bond Market?

Trump wants to run the economy hot to out of debt. So, what are the implications for markets? The Trump administration’s plan for the next 12 months could look like the following: 1) More tariffs: threaten big tariffs by Aug 1st, and ‘’close deals’’ with higher tariff rates before...

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year, I thought it would be a good idea to review the key areas of analysis for the stock market.Such a review includes my...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities, and equities. Central banks once again take the spotlight, with both the Reserve Bank of Australia (RBA) and the Reserve Bank of New...

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting multiple U.S. trading partners.Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...